购物车
全部删除
您的购物车当前为空
Anticancer agent 183 (example 48), a non-agonistic PPARG modulator, exhibits high affinity for PPARG (PPARγ) and inhibits kinase-mediated phosphorylation of this target. It is utilized in research on metabolic diseases to minimize side effects [1].

Anticancer agent 183 (example 48), a non-agonistic PPARG modulator, exhibits high affinity for PPARG (PPARγ) and inhibits kinase-mediated phosphorylation of this target. It is utilized in research on metabolic diseases to minimize side effects [1].
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
| 产品描述 | Anticancer agent 183 (example 48), a non-agonistic PPARG modulator, exhibits high affinity for PPARG (PPARγ) and inhibits kinase-mediated phosphorylation of this target. It is utilized in research on metabolic diseases to minimize side effects [1]. |
| 分子量 | 540.69 |
| 分子式 | C34H40N2O4 |
| CAS No. | 1415321-54-8 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多